Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGI NYSE:PBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGIAlamos Gold$25.65-1.2%$26.29$17.42▼$31.00$10.78B0.513.48 million shs2.79 million shsPBHPrestige Consumer Healthcare$66.51+1.8%$78.07$62.95▼$90.04$3.27B0.43383,374 shs646,922 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGIAlamos Gold-0.51%-1.01%-2.37%+9.21%+43.64%PBHPrestige Consumer Healthcare+1.95%-11.83%-14.46%-23.93%+0.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGIAlamos Gold3.5316 of 5 stars2.64.01.70.03.21.71.9PBHPrestige Consumer Healthcare4.4021 of 5 stars3.34.00.03.51.71.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGIAlamos Gold 3.11Buy$30.3818.42% UpsidePBHPrestige Consumer Healthcare 2.50Moderate Buy$93.3340.33% UpsideCurrent Analyst Ratings BreakdownLatest BET, 888, PBH, and AGI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025PBHPrestige Consumer HealthcareCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$105.00 ➝ $100.008/5/2025AGIAlamos GoldNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform7/15/2025AGIAlamos GoldCIBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform7/9/2025AGIAlamos GoldStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy7/8/2025AGIAlamos GoldStifel CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGIAlamos Gold$1.35B8.01$1.28 per share20.06$8.93 per share2.87PBHPrestige Consumer Healthcare$1.14B2.88$5.43 per share12.25$37.70 per share1.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGIAlamos Gold$284.30M$0.8330.9022.110.5722.99%10.67%7.16%N/APBHPrestige Consumer Healthcare$214.60M$4.2615.6113.972.0219.02%12.69%6.79%N/ALatest BET, 888, PBH, and AGI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q1 2026PBHPrestige Consumer Healthcare$1.01$0.95-$0.06$0.95$260.71 million$249.53 million7/30/2025Q2 2025AGIAlamos Gold$0.33$0.34+$0.01$0.38$400.61 million$438.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGIAlamos Gold$0.100.39%N/A12.05%N/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/ALatest BET, 888, PBH, and AGI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/30/2025AGIAlamos Goldquarterly$0.02500.4%6/12/20256/12/20256/26/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGIAlamos Gold0.071.491.00PBHPrestige Consumer Healthcare0.554.382.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGIAlamos Gold64.33%PBHPrestige Consumer Healthcare99.95%Insider OwnershipCompanyInsider OwnershipAGIAlamos Gold0.46%PBHPrestige Consumer Healthcare1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGIAlamos Gold2,400420.43 million418.50 millionOptionablePBHPrestige Consumer Healthcare54049.21 million48.53 millionOptionableBET, 888, PBH, and AGI HeadlinesRecent News About These CompaniesInformed Momentum Co LLC Makes New $3.56 Million Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)August 13 at 6:27 AM | marketbeat.comEquities Analysts Offer Predictions for PBH Q3 EarningsAugust 12 at 4:26 AM | marketbeat.comPrestige Consumer Healthcare (NYSE:PBH) Price Target Lowered to $100.00 at Canaccord Genuity GroupAugust 10 at 5:58 PM | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkAugust 10 at 10:15 AM | finance.yahoo.comTownsquare Capital LLC Has $7.82 Million Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)August 10 at 5:59 AM | marketbeat.comPrestige Consumer Healthcare (NYSE:PBH) Rating Lowered to "Hold" at Wall Street ZenAugust 10 at 3:17 AM | marketbeat.comPrestige Consumer Healthcare (NYSE:PBH) Sets New 1-Year Low Following Weak EarningsAugust 10 at 2:01 AM | americanbankingnews.comPrestige Consumer Healthcare (NYSE:PBH) Sets New 52-Week Low Following Weak EarningsAugust 9, 2025 | marketbeat.comFederated Hermes Inc. Cuts Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)August 9, 2025 | marketbeat.comPrestige Consumer Healthcare (NYSE:PBH) Stock Rating Lowered by Wall Street ZenAugust 9, 2025 | americanbankingnews.comPrestige Consumer Healthcare (NYSE:PBH) Shares Down 10% - Time to Sell?August 8, 2025 | marketbeat.comPrestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesAugust 8, 2025 | msn.comPrestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recoveryAugust 8, 2025 | msn.comPrestige Consumer Healthcare (NYSE:PBH) Issues FY 2026 Earnings GuidanceAugust 8, 2025 | marketbeat.comNeumeier Poma Investment Counsel LLC Takes Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)August 8, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comPrestige Consumer Healthcare Inc. 2026 Q1 - Results - Earnings Call PresentationAugust 8, 2025 | seekingalpha.comPrestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue EstimatesAugust 7, 2025 | zacks.comPrestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results | PBH Stock NewsAugust 7, 2025 | gurufocus.comPrestige Consumer Healthcare Acquires Pillar5 Pharma for ExpansionAugust 7, 2025 | tipranks.comPrestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter ResultsAugust 7, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025Golden Cross Alert: 3 Stocks With Serious Upside PotentialBy Chris Markoch | July 31, 2025Pelosi Makes Big Bet on Broadcom—Here’s Why It MattersBy Gabriel Osorio-Mazilli | July 15, 2025Analysts Make a Quantum Bet on D-Wave's Cryogenic Packaging By Nathan Reiff | August 4, 2025Tesla: 2 Plays Ahead of Next Week's Earnings ReportBy Sam Quirke | July 15, 2025BET, 888, PBH, and AGI Company DescriptionsAlamos Gold NYSE:AGI$25.65 -0.30 (-1.16%) Closing price 03:59 PM EasternExtended Trading$25.77 +0.12 (+0.47%) As of 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alamos Gold Inc. engages in the acquisition, exploration, development, and extraction of precious metals in Canada and Mexico. The company primarily explores for gold deposits. It holds 100% interest in the Young-Davidson mine and Island Gold mine located in the Ontario, Canada; Mulatos mine located in the Sonora, Mexico; and Lynn Lake project situated in the Manitoba, Canada. The company also holds interest in the Quartz Mountain project located in the Oregon United states. Alamos Gold Inc. was founded in 2003 and is based in Toronto, Canada.Prestige Consumer Healthcare NYSE:PBH$66.51 +1.20 (+1.84%) Closing price 03:59 PM EasternExtended Trading$66.43 -0.08 (-0.12%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests 5 Stocks Insiders Are Selling That Analysts Say Buy CoreWeave Pulls Back Into a Screaming Buy Amazon’s Bears Have Raised the White Flag—Get Excited Rocket Lab Scores Analyst Upgrades, Finalizes Geost Takeover Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity Catalysts Align: Archer Beats Estimates, Delivers Aircraft to UAE Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access